143 related articles for article (PubMed ID: 9624296)
21. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
[TBL] [Abstract][Full Text] [Related]
22. Uterine-associated serine protease inhibitors stimulate deoxyribonucleic acid synthesis in porcine endometrial glandular epithelial cells of pregnancy.
Badinga L; Michel FJ; Simmen RC
Biol Reprod; 1999 Aug; 61(2):380-7. PubMed ID: 10411515
[TBL] [Abstract][Full Text] [Related]
23. Distribution of secretory leukoprotease inhibitor in the human nasal airway.
Lee CH; Igarashi Y; Hohman RJ; Kaulbach H; White MV; Kaliner MA
Am Rev Respir Dis; 1993 Mar; 147(3):710-6. PubMed ID: 8095126
[TBL] [Abstract][Full Text] [Related]
24. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
25. Location of the protease-inhibitory region of secretory leukocyte protease inhibitor.
Eisenberg SP; Hale KK; Heimdal P; Thompson RC
J Biol Chem; 1990 May; 265(14):7976-81. PubMed ID: 2110563
[TBL] [Abstract][Full Text] [Related]
26. [Regulation of secretory leukoprotease inhibitor gene expression].
Kikuchi T; Abe T
Nihon Rinsho; 1996 Feb; 54(2):405-10. PubMed ID: 8838088
[TBL] [Abstract][Full Text] [Related]
27. Secretory leukocyte protease inhibitor, but not alpha-1 protease inhibitor, blocks tryptase-induced bronchoconstriction.
Forteza RM; Ahmed A; Lee T; Abraham WM
Pulm Pharmacol Ther; 2001; 14(2):107-10. PubMed ID: 11273791
[TBL] [Abstract][Full Text] [Related]
28. Secretory leukoprotease inhibitor augments hepatocyte growth factor production in human lung fibroblasts.
Kikuchi T; Abe T; Yaekashiwa M; Tominaga Y; Mitsuhashi H; Satoh K; Nakamura T; Nukiwa T
Am J Respir Cell Mol Biol; 2000 Sep; 23(3):364-70. PubMed ID: 10970828
[TBL] [Abstract][Full Text] [Related]
29. Antibacterial activity of antileukoprotease.
Hiemstra PS; Maassen RJ; Stolk J; Heinzel-Wieland R; Steffens GJ; Dijkman JH
Infect Immun; 1996 Nov; 64(11):4520-4. PubMed ID: 8890201
[TBL] [Abstract][Full Text] [Related]
30. Modulation of secretory leukoprotease inhibitor gene expression in human bronchial epithelial cells by phorbol ester.
Maruyama M; Hay JG; Yoshimura K; Chu CS; Crystal RG
J Clin Invest; 1994 Jul; 94(1):368-75. PubMed ID: 7913712
[TBL] [Abstract][Full Text] [Related]
31. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
[TBL] [Abstract][Full Text] [Related]
32. Secretory leukocyte protease inhibitor binding to mRNA and DNA as a possible cause of toxicity to Escherichia coli.
Miller KW; Evans RJ; Eisenberg SP; Thompson RC
J Bacteriol; 1989 Apr; 171(4):2166-72. PubMed ID: 2467900
[TBL] [Abstract][Full Text] [Related]
33. Secretory leukocyte protease inhibitor inhibits infection of monocytes and lymphocytes with human immunodeficiency virus type 1 but does not interfere with transcytosis of cell-associated virus across tight epithelial barriers.
Hocini H; Becquart P; Bouhlal H; Adle-Biassette H; Kazatchkine MD; Bélec L
Clin Diagn Lab Immunol; 2000 May; 7(3):515-8. PubMed ID: 10799472
[TBL] [Abstract][Full Text] [Related]
34. Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress.
Vogelmeier C; Biedermann T; Maier K; Mazur G; Behr J; Krombach F; Buhl R
Eur Respir J; 1997 Sep; 10(9):2114-9. PubMed ID: 9311513
[TBL] [Abstract][Full Text] [Related]
35. Expression of the secretory leukoprotease inhibitor gene in epithelial cells.
Abe T; Kobayashi N; Yoshimura K; Trapnell BC; Kim H; Hubbard RC; Brewer MT; Thompson RC; Crystal RG
J Clin Invest; 1991 Jun; 87(6):2207-15. PubMed ID: 1674946
[TBL] [Abstract][Full Text] [Related]
36. Structure of the murine secretory leukoprotease inhibitor (Slpi) gene and chromosomal localization of the human and murine SLPI genes.
Kikuchi T; Abe T; Hoshi S; Matsubara N; Tominaga Y; Satoh K; Nukiwa T
Am J Respir Cell Mol Biol; 1998 Dec; 19(6):875-80. PubMed ID: 9843921
[TBL] [Abstract][Full Text] [Related]
37. Effect of the secretory leucocyte proteinase inhibitor (SLPI) on Candida albicans biological processes: a therapeutic alternative?
Curvelo JA; Barreto AL; Portela MB; Alviano DS; Holandino C; Souto-Padrón T; Soares RM
Arch Oral Biol; 2014 Sep; 59(9):928-37. PubMed ID: 24907522
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of human mast cell chymase by secretory leukocyte proteinase inhibitor: enhancement of the interaction by heparin.
Walter M; Plotnick M; Schechter NM
Arch Biochem Biophys; 1996 Mar; 327(1):81-8. PubMed ID: 8615699
[TBL] [Abstract][Full Text] [Related]
39. DNA from bronchial secretions modulates elastase inhibition by alpha(1)-proteinase inhibitor and oxidized secretory leukoprotease inhibitor.
Ying QL; Simon SR
Am J Respir Cell Mol Biol; 2000 Oct; 23(4):506-13. PubMed ID: 11017916
[TBL] [Abstract][Full Text] [Related]
40. Analysis of secretory leukocyte protease inhibitor (SLPI) in bronchial secretions from patients with hypersecretory respiratory diseases.
Kouchi I; Yasuoka S; Ueda Y; Ogura T
Tokushima J Exp Med; 1993 Jun; 40(1-2):95-107. PubMed ID: 8105562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
